{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T13:06:40Z","timestamp":1775135200691,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1124\/dmd.112.045195","type":"journal-article","created":{"date-parts":[[2012,4,21]],"date-time":"2012-04-21T00:24:03Z","timestamp":1334967843000},"page":"1441-1448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Hydralazine As a Selective Probe Inactivator of Aldehyde Oxidase in Human Hepatocytes: Estimation of the Contribution of Aldehyde Oxidase to Metabolic Clearance"],"prefix":"10.1016","volume":"40","author":[{"given":"Timothy J.","family":"Strelevitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine C.","family":"Orozco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Scott","family":"Obach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.112.045195_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2133\/dmpk.DMPK-11-RG-097","article-title":"A practical and direct comparison of intrinsic metabolic clearance of several non-CYP enzyme substrates in freshly isolated and cryopreserved hepatocytes","volume":"27","author":"Akabane","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.112.045195_bib2","series-title":"Enzyme Systems That Metabolise Drugs and Other Xenobiotics","first-page":"147","article-title":"Molybdenum hydroxylases","author":"Beedham","year":"2002"},{"key":"10.1124\/dmd.112.045195_bib3","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1021\/tx0200109","article-title":"Cytochrome P450 3A4-mediated bioactivation of raloxifene: irreversible enzyme inhibition and thiol adduct formation","volume":"15","author":"Chen","year":"2002","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.112.045195_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0090-9556(25)06527-4","article-title":"Role of aldehyde oxidase in the in vitro conversion of famciclovir to penciclovir in human liver","volume":"23","author":"Clarke","year":"1995","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.045195_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/00498259409043219","article-title":"Biotransformation of carbazeran in guinea pig: effect of hydralazine pretreatment","volume":"24","author":"Critchley","year":"1994","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.112.045195_bib6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1124\/dmd.109.030783","article-title":"Cross-species comparison of the metabolism and excretion of zoniporide: contribution of aldehyde oxidase to interspecies differences","volume":"38","author":"Dalvie","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.045195_bib7","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1124\/dmd.110.032375","article-title":"Species-specific metabolism of SGX523 by aldehyde oxidase and the toxicological implications","volume":"38","author":"Diamond","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.045195_bib8","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0959-8049(02)00020-5","article-title":"Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration","volume":"38","author":"Dittrich","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1124\/dmd.112.045195_bib9","doi-asserted-by":"crossref","first-page":"678","DOI":"10.2174\/138920010794233503","article-title":"Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution","volume":"11","author":"Emoto","year":"2010","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.112.045195_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/bj20030121","article-title":"Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology","volume":"372","author":"Garattini","year":"2003","journal-title":"Biochem J"},{"key":"10.1124\/dmd.112.045195_bib11","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3109\/03602532.2011.560606","article-title":"Increasing recognition of the importance of aldehyde oxidase in drug development and discovery","volume":"43","author":"Garattini","year":"2011","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.112.045195_bib12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1517\/17425255.2012.663352","article-title":"The role of aldehyde oxidase in drug metabolism","volume":"8","author":"Garattini","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.112.045195_bib13","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0009-9236(98)90139-4","article-title":"Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo","volume":"64","author":"Greenblatt","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.112.045195_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0006-2952(94)90237-2","article-title":"Characterization of dextromethorphan N-demethylation by human liver microsomes. Contribution of the cytochrome P450 3A (CYP3A) subfamily","volume":"48","author":"Gorski","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.112.045195_bib15","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1124\/dmd.111.043828","article-title":"The impact of single nucleotide polymorphisms on human aldehyde oxidase","volume":"40","author":"Hartmann","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.045195_bib16","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/0006-2952(94)90520-7","article-title":"Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance","volume":"47","author":"Houston","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.112.045195_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1124\/dmd.111.042861","article-title":"Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepatocytes","volume":"40","author":"Hutzler","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.045195_bib18","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1016\/0006-2952(85)90280-1","article-title":"Hydralazine: a potent inhibitor of aldehyde oxidase activity in vitro and in vivo","volume":"34","author":"Johnson","year":"1985","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.112.045195_bib19","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0090-9556(24)14921-5","article-title":"Aldehyde oxidase-dependent marked species difference in hepatic metabolism of the sedative-hypnotic, zaleplon, between monkeys and rats","volume":"27","author":"Kawashima","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.045195_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/00498258509045354","article-title":"Oxidative metabolism of carbazeran in vitro by liver cytosol of baboon and man","volume":"15","author":"Kaye","year":"1985","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.112.045195_bib21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1124\/dmd.108.023853","article-title":"Prediction of drug clearance by glucuronidation from in vitro data: use of combined cytochrome P450 and UDP-glucuronosyltransferase cofactors in alamethicin-activated human liver microsomes","volume":"37","author":"Kilford","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.045195_bib22","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/00498250210158915","article-title":"Metabolism of zaleplon by human liver: evidence for involvement of aldehyde oxidase","volume":"32","author":"Lake","year":"2002","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.112.045195_bib23","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.1021\/jm900729s","article-title":"Discovery of azetidinyl ketolides for the treatment of susceptible and multidrug resistant community-acquired respiratory tract infections","volume":"52","author":"Magee","year":"2009","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.112.045195_bib24","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1124\/dmd.104.000026","article-title":"Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance","volume":"32","author":"McGinnity","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.045195_bib25","first-page":"201","article-title":"The behavior and significance of slow-binding enzyme inhibitors","volume":"61","author":"Morrison","year":"1988","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"key":"10.1124\/dmd.112.045195_bib26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1124\/dmd.32.1.89","article-title":"Potent inhibition of human liver aldehyde oxidase by raloxifene","volume":"32","author":"Obach","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.045195_bib27","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2174\/156802611794480873","article-title":"Predicting clearance in humans from in vitro data","volume":"11","author":"Obach","year":"2011","journal-title":"Curr Top Med Chem"},{"key":"10.1124\/dmd.112.045195_bib28","doi-asserted-by":"crossref","first-page":"8441","DOI":"10.1021\/jm100888d","article-title":"Aldehyde oxidase: an enzyme of emerging importance in drug discovery","volume":"53","author":"Pryde","year":"2010","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.112.045195_bib29","first-page":"805","article-title":"In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit, and rat liver","volume":"25","author":"Rashidi","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.045195_bib30","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/00498250210158221","article-title":"Inhibition of zaleplon metabolism by cimetidine in the human liver: in vitro studies with subcellular fractions and precision-cut liver slices","volume":"32","author":"Renwick","year":"2002","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.112.045195_bib31","doi-asserted-by":"crossref","first-page":"19748","DOI":"10.1074\/jbc.M600850200","article-title":"Avian and canine aldehyde oxidases. Novel insights into the biology and evolution of molybdo-flavoenzymes","volume":"281","author":"Terao","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.112.045195_bib32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1124\/dmd.110.036343","article-title":"Validation of isolated metabolites from drug metabolism studies as analytical standards by quantitative NMR","volume":"39","author":"Walker","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.045195_bib33","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2125.1995.tb04472.x","article-title":"Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers\u2014N-desisopropylation is mediated mainly by CYP1A2","volume":"39","author":"Yoshimoto","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.112.045195_bib34","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1124\/dmd.110.033555","article-title":"In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase","volume":"38","author":"Zientek","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.045195_bib35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.vascn.2008.05.131","article-title":"Development of an in vitro drug-drug interaction assay to simultaneously monitor five cytochrome P450 isoforms and performance assessment using drug library compounds","volume":"58","author":"Zientek","year":"2008","journal-title":"J Pharmacol Toxicol Methods"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624227380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624227380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.112.045195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T20:11:10Z","timestamp":1739909470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624227380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0090955624227380"],"URL":"https:\/\/doi.org\/10.1124\/dmd.112.045195","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydralazine As a Selective Probe Inactivator of Aldehyde Oxidase in Human Hepatocytes: Estimation of the Contribution of Aldehyde Oxidase to Metabolic Clearance","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.112.045195","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}